For example, tissue-specific expression of putative HR pathway regulators targeted by HORMAD1 might explain why HORMAD1 stimulates HR in lung adenocarcinomas and basal breast cancer cells and but inhibits HR in TNBC. Here, HORMAD1 is linked to breast carcinoma.